|
|
||||||||
Papers In Press, published online ahead of print December 7, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dept. of Physiology, Pusan National University, College of Medicine, Busan 602-739
Corresponding Author: jhkimst{at}pusan.ac.kr
Sphingosylphosphorylcholine (SPC) has been implicated in a variety of cellular responses, including proliferation and differentiation. In the present study, we demonstrated that D-erythro-, but not L-threo-SPC, stereo-selectively stimulated the proliferation of human adipose tissue-derived mesenchymal stem cells (hADSCs) with a maximal increase at 5
Accepted on December 7, 2005
Sphingosylphosphorylcholine induces proliferation of human adipose tissue-derived mesenchymal stem cells via activation of JNK
M and increased the intracellular concentration of Ca2+ ([Ca2+]i) in hADSCs, which do not express known SPC receptors, i.e. OGR1, GPR4, G2A, and GPR12. The SPC-induced proliferation and increase in [Ca2+]i were sensitive to pertussis toxin (PTX) and phospholipase C (PLC) inhibitor U73122, suggesting that PTX-sensitve G proteins, Gi or Go, and PLC are involved in the SPC-induced proliferation. In addition, SPC treatment induced the phosphorylation of c-Jun and ERK, and the SPC-induced proliferation was completely prevented by pretreatment with Jun N-terminal kinase (JNK)-specific inhibitor SP600125, but not with MEK-specific inhibitor U0126. Furthermore, the SPC-induced proliferation and JNK activation were completely attenuated by over-expression of a dominant negative mutant of JNK2, and the SPC-induced activation of JNK was inhibited by pretreatment with PTX or U73122. Treatment of hADSCs with LPA receptor antagonist, Ki16425, had no impact on the SPC-induced increase in [Ca2+]i. However, the SPC-induced proliferation was partially, but significantly, attenuated by pretreatment of the cells with Ki16425. These results indicate that SPC stimulates proliferation of hADSCs through Gi/o-PLC-JNK pathway, and that LPA receptors may be responsible in part for the SPC-induced proliferation.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
E. S. Jeon, H. J. Moon, M. J. Lee, H. Y. Song, Y. M. Kim, M. Cho, D.-S. Suh, M.-S. Yoon, C. L. Chang, J. S. Jung, et al. Cancer-Derived Lysophosphatidic Acid Stimulates Differentiation of Human Mesenchymal Stem Cells to Myofibroblast-Like Cells Stem Cells, March 1, 2008; 26(3): 789 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schaffler and C. Buchler Concise Review: Adipose Tissue-Derived Stromal Cells--Basic and Clinical Implications for Novel Cell-Based Therapies Stem Cells, April 1, 2007; 25(4): 818 - 827. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Jeon, H. J. Moon, M. J. Lee, H. Y. Song, Y. M. Kim, Y. C. Bae, J. S. Jung, and J. H. Kim Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-{beta}-dependent mechanism J. Cell Sci., December 1, 2006; 119(23): 4994 - 5005. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |